Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn

Author(s)/Faculty: Bruce E. Sands, MD, MS; William J. Sandborn, MD
Release Date: 3/24/2021Expiration Date: 3/23/2022
Credit Type: CMENumber of Credits: 0.25
Content Type: PodcastProvider:
In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe Crohn’s disease.